IMPAACT Studies in Development
The study you are looking for is in protocol development.
As the study protocol reaches Version 1.0, a study page will be developed.
|
Study Number (DAIDS ID) |
Study Title | Status |
|---|---|---|
|
IMPAACT 2017 (TBD) |
Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolescents |
In Development |
|
IMPAACT 2016 (TBD) |
Evaluating a Group-Based Intervention to Improve Mental Health and ART Adherence in Adolescents Living with HIV in Low Resource Settings |
In Development |
|
IMPAACT 2014 (34150) |
Phase I/II Study of the Pharmacokinetics, Safety and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-infected Children and Adolescents |
In Development |
|
IMPAACT 2015 (35123) |
Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults with Cognitive Impairment |
In Development |
|
IMPAACT 2009 (30020) |
Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Postpartum in Adolescents and Young Women and their Infants |
In Development |
|
IMPAACT 2003B (12041) |
(Phoenix) Protecting Households on Exposure to Newly Diagnosed Index Multidrug-Resistant TB Patients |
In Development |